Axogen (AXGN) Interest Coverage Ratio Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.86% |
| Dec 31, 2025 | 8.83% |
| Sep 30, 2025 | 19.27% |
| Jun 30, 2025 | 14.91% |
| Mar 31, 2025 | 69.39% |
| Dec 31, 2024 | 14.91% |
| Sep 30, 2024 | 81.96% |
| Jun 30, 2024 | 80.52% |
| Mar 31, 2024 | 69.38% |
| Dec 31, 2023 | 52.23% |
| Sep 30, 2023 | -14.94% |
| Jun 30, 2023 | -39.41% |
| Mar 31, 2023 | 37.96% |
| Dec 31, 2022 | 179.99% |
| Sep 30, 2022 | 38.90% |
| Jun 30, 2022 | 20.94% |
| Mar 31, 2022 | 37.23% |
| Dec 31, 2021 | 127.59% |
| Sep 30, 2021 | -71.38% |
| Jun 30, 2021 | -55.78% |
| Mar 31, 2021 | -39.89% |
| Dec 31, 2020 | -25.87% |
| Sep 30, 2020 | -7.42% |
| Jun 30, 2020 | -163.32% |
| Mar 31, 2020 | -154.77% |
| Dec 31, 2019 | -226.58% |
| Sep 30, 2019 | -267.31% |
| Jun 30, 2019 | -235.10% |
| Mar 31, 2019 | -210.86% |
| Dec 31, 2018 | -100.91% |
| Sep 30, 2018 | 236.56% |
| Jun 30, 2018 | -37.63% |
| Mar 31, 2018 | -369.99% |
| Dec 31, 2017 | 18.13% |
| Sep 30, 2017 | -131.53% |
| Jun 30, 2017 | -52.06% |
| Mar 31, 2017 | -84.11% |
| Dec 31, 2016 | 38.21% |
| Sep 30, 2016 | 33.36% |
| Jun 30, 2016 | 17.34% |
| Mar 31, 2016 | 10.08% |
| Dec 31, 2015 | 10.03% |
| Sep 30, 2015 | 16.55% |